Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend

Bulletin Express

04/14

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.

The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1108089810"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108089810\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108089810?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-14 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108089810","market":"us","top_or_hot":-1,"title":"Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend","media":"Bulletin Express","content":"<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChunli Medical Sets 29 April 2026 Board Meeting to Approve Q1 Results and Discuss Interim Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-14 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.</p>\n<p>The notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01858","symbol_name":"春立醫療","start_time":0,"source_url":"","article_id":"1108089810","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108089810","pubTimestamp":1776157413,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01858":"春立医疗"},"translate_title":"春立医疗定于2026年4月29日召开董事会批准第一季度业绩并讨论中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01858":1},"content_text":"Beijing Chunlizhengda Medical Instruments Co., Ltd. (Chunli Medical) has scheduled a board meeting for Wednesday, 29 April 2026. Directors will review and approve the consolidated financial results for the three months ended 31 March 2026 and consider the declaration of an interim dividend.\nThe notice, dated 14 April 2026, lists the current board composition as four executive directors—Shi Wenling, Shi Chunbao, Yue Shujun and Xie Feng Bao—one non-executive director, Wang Xin, and three independent non-executive directors, Xu Hong, Weng Jie and Wong Tak Shing.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}